Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Operating Leases: 2012-2023

Historic Operating Leases for Ascendis Pharma A (ASND) over the last 3 years, with Dec 2023 value amounting to $91.0 million.

  • Ascendis Pharma A's Operating Leases fell 6.48% to $91.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $91.0 million, marking a year-over-year decrease of 6.48%. This contributed to the annual value of $91.0 million for FY2023, which is 6.48% down from last year.
  • According to the latest figures from Q4 2023, Ascendis Pharma A's Operating Leases is $91.0 million, which was down 7.20% from $98.1 million recorded in Q3 2023.
  • Over the past 5 years, Ascendis Pharma A's Operating Leases peaked at $120.1 million during Q4 2021, and registered a low of -$3.3 million during Q3 2019.
  • Over the past 3 years, Ascendis Pharma A's median Operating Leases value was $108.0 million (recorded in 2021), while the average stood at $105.8 million.
  • Per our database at Business Quant, Ascendis Pharma A's Operating Leases slumped by 99.85% in 2019 and then soared by 356,868.93% in 2020.
  • Ascendis Pharma A's Operating Leases (Quarterly) stood at $30,720 in 2019, then surged by 356,868.93% to $109.7 million in 2020, then increased by 9.49% to $120.1 million in 2021, then dropped by 18.94% to $97.3 million in 2022, then decreased by 6.48% to $91.0 million in 2023.
  • Its Operating Leases was $91.0 million in Q4 2023, compared to $98.1 million in Q3 2023 and $97.3 million in Q4 2022.